Recently, an increased expression of the dihydrolipoamide S-succinyltransferase (DLST) gene has been shown to predict poor outcome of neuroblastoma and triple-negative breast cancer (TNBC) [1, 2]. The gene discussed is DLST; the disease is neuroblastoma.